US firm KnipBio has successfully completed a feed efficacy trial on Atlantic salmon, marking the third version of its single-cell protein to pass quality and efficacy trials. Read more >>
ALK today announced that it has finalised its strategy for entering the US market for epinephrine (adrenaline) auto-injectors (EAIs)…
read moreIt’s about time Danielle Staub took a radical new approach to her love life — and she seems to…
read morePlateletBio, a pioneering biotechnology company developing next-generation allogeneic cell therapies for treatment of human diseases, has named Steven M….
read moreAutoimmune Immunomodulator Market 2016- Avaxia Biologics, Enlivex Therapeutics, Biogen Idec, AstraZeneca, Eli Lilly. A market study based on the Autoimmune…
read moreEmerging healthcare IT start-up OmniLife has added industry-experienced professional Paul Winandy to its Board of Directors.Paul Winandy, a health…
read moreWhen asked to play a game to see who could rip the Christmas paper from the boxes the fastest…
read moreEllie Leden’s parents hope people will listen to their child’s plight and understand how much a new pair of…
read moreThe top-performing public biotech in Massachusetts over the past year is located in a nondescript brick building with no…
read moreThe eSight glasses are electronic glasses that have a high speed and high resolution camera in the middle of…
read more…Fortunately, many of these challenges may be alleviated when second-generation Covid vaccines come on the market. One candidate currently…
read more